Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Trial to Determine the Efficacy of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand

NCT00006327 is registered in ClinicalTrials.gov with VaxGen as lead sponsor.

NCT NCT00006327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Trial to Determine the Efficacy of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand
Lead sponsor
VaxGen
Phase
Phase 3
Overall status
Completed
Start date
March 31, 1999
Completion date
August 31, 2000
Enrollment
2,500
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections, hiv seronegativity